Laparoscopic Surgical Procedures Market Size, Share and Global Trend By Type (Gastrointestinal, Gynecological, ENT (Ear, Nose, Throat), Others), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others), and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
Internal abdominal parts such as appendix, gallbladder, spleen, stomach, liver, pelvic & reproductive organs and pancreas are examined and treated by using laparoscopic surgical procedure with the help of minimal incision. Laparoscopic procedures are effective in detecting an abdominal tumor, liver disease, cancer progress, and urologic diseases. Also, along with the detection of abdominal abnormalities, laparoscopic procedures are widely used during intestinal surgeries such as rectal prolapse, ulcerative colitis, Crohn’s disease, and others. According to Crohn's & Colitis Foundation, an estimated 780,000 people in the U.S. are affected by Crohn’s disease each year.
Rising prevalence of abdominal abnormalities, growing prevalence of cancer and growth in urologic conditions are some of the factors driving the growth of the global laparoscopic surgical procedures market. Also, certain benefits served by a laparoscopic surgical procedure such as minimal invasion, better precision as compared to open surgical procedures, minimal recovery time, minimal risk and minimal procedural time are expected to boost the growth of global laparoscopic surgical procedures during the forecast period.
To gain extensive insights into the market, Request for Customization
However, increased risk of intense abdominal pain, lack of healthcare infrastructure in emerging nations and risk of bleeding at the incision site are some of the factors restraining the growth of global laparoscopic surgical procedures.
Key Players Covered
Some of the major companies that are present in the global laparoscopic surgical procedures market are Intuitive Surgical Inc., Silex Medical, LLC., Life Care Medical Devices Limited, Cook Medical Incorporated, Fortimedix Surgical, TransEnterix, Inc., Encision Inc., Applied Medical Resources Corporation, Microline Surgical Inc., Hill-Rom Holdings Inc., and others.
SEGMENTATION
SEGMENTATION | DETAILS |
By Type | · Gastrointestinal · Gynecological · ENT (Ear, Nose, Throat) · Others |
By End User | · Hospitals · Clinics · Ambulatory Surgery Centres · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
In 2018, among end user, the hospitals segment dominated the global laparoscopic surgical procedures market due to increase in demand for minimal invasive surgeries (MIS) and upsurge in governmental initiatives to improve healthcare facilities. The ambulatory surgery centers segment is projected to grow at comparatively higher CAGR during the forecast period.
Key Insights
- Prevalence of cancer, By Key Regions
- Pricing Analysis of Key Players in Major Countries/Regions
- Number of inpatient and outpatient by major countries/ region
- Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions
Regional Analysis
North America dominated the global laparoscopic surgical procedures market in 2018 owing to the rise in prevalence of chronic pelvic pain, liver disease, infertility and rising prevalence of abdominal abnormalities. According to Centres for Disease Control and Prevention, in 2016, an estimated 4.9 million people were affected by liver disease in the U.S. Increasing preference of healthcare providers for laparoscopic surgical procedures owing to their clinical benefits over open surgeries is among the major factor responsible for higher adoption of these procedures in the U.S. The Asia Pacific region is projected to register comparatively higher CAGR during 2019-2026, owing to increasing number of surgical procedures, and developing healthcare infrastructure in emerging countries, anticipated to drive the adoption of laparoscopic surgical procedures during forecast period.
Key Industry Developments
- In October 2017, TransEnterix Surgical Inc., received U.S. Food and Drug Administration approval for its Senhance System, a new robotically-assisted surgical device (RASD) that can help facilitate minimally invasive surgery.
- In August 2017, Fortimedix Surgical announced the U.S. launch of symphonX Instruments short. This new product line offers shorter instruments that broaden surgical applicability of the symphonX Surgical Platform, further increasing the ease of use for surgeons during specific surgical procedures.
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
